carbohydr
composit
immunoreact
glycoprotein
coronaviru
tgev
studi
differ
stage
matur
biosynthesi
analyz
presenc
tunicamycin
monensin
effect
treatment
endoglycosidas
h
f
glycopeptidas
f
precursor
matur
form
also
examin
speci
character
high
mannos
form
respect
speci
complex
type
glycosyl
form
two
protein
present
mainli
speci
matur
virion
wherea
form
detect
thu
impli
two
protein
undergo
golgi
modif
far
differ
effici
anti
monoclon
antibodi
examin
reactiv
toward
polypeptid
speci
either
treat
endo
h
produc
presenc
tunicamycin
found
among
four
major
antigen
site
previous
defin
delma
et
al
site
c
amino
acid
notabl
express
unglycosyl
polypeptid
wherea
three
site
depend
upon
oregiycosyl
ii
three
four
antim
mab
test
recogn
unglycosyl
polypeptid
data
led
us
conclud
cotransl
termin
glycosyl
essenti
requir
acquisit
mainten
antigen
tgev
glycoprotein
c
rendenc
h
laud
viru
research
carbohydr
composit
immunoreact
glycoprotein
coronaviru
tgev
studi
differ
stage
matur
biosynthesi
analyz
presenc
tunicamycin
monensin
effect
treatment
endoglycosidas
h
f
glycopeptidas
f
precursor
matur
form
also
examin
speci
character
high
mannos
form
respect
speci
complex
type
glycosyl
form
two
protein
present
mainli
speci
matur
virion
wherea
form
detect
thu
impli
two
protein
undergo
golgi
modif
far
differ
effici
anti
monoclon
antibodi
examin
reactiv
toward
polypeptid
speci
either
treat
endo
h
produc
presenc
tunicamycin
found
among
four
major
antigen
site
previous
defin
delma
et
al
site
c
amino
acid
notabl
express
unglycosyl
polypeptid
wherea
three
site
depend
upon
oregiycosyl
ii
three
four
antim
mab
test
recogn
unglycosyl
polypeptid
data
led
us
conclud
cotransl
termin
glycosyl
essenti
requir
acquisit
mainten
antigen
tgev
glycoprotein
coronavirus
envelop
virus
larg
positivestrand
rna
genom
virion
contain
basic
two
envelop
protein
tiansmembran
glycoprotein
larg
glycoprotein
form
petalshap
peplom
spike
protrud
virion
envelop
see
spaan
et
al
review
protein
assum
mediat
attach
virion
cell
induc
cell
fusion
major
target
virusneutr
antibodi
type
glycoprotein
larg
predomin
ectodomain
cotransl
glycosyl
mani
potenti
acceptor
site
nlink
glycosyl
found
sequenc
viru
matur
carbohydr
undergo
golgi
modif
niemann
et
al
sturman
holm
may
cleav
two
subunit
nearli
equival
size
depend
viru
cell
system
aminosubunit
sl
carboxysubunit
correspond
approxim
globular
domain
stalk
spike
respect
spike
form
oligom
recent
propos
trimer
interchain
elong
coiledcoil
structur
predict
carboxydomain
describ
influenza
viru
may
contribut
stabil
oligom
protein
accumul
golgi
apparatu
postul
role
viru
matur
determin
site
bud
virion
protein
tgev
also
report
interferogen
glycoprotein
abl
induc
interferon
alpha
synthesi
leucocyt
charley
laud
unlik
protein
buri
mainli
viral
particl
less
ntermin
residu
expos
outer
surfac
viru
membran
next
residu
form
three
hydrophob
ahelic
span
membran
three
time
rest
molecul
locat
interior
viru
particl
ectodomain
carri
glycosyl
site
differ
type
linkag
glycan
see
sturman
holm
review
olink
murin
hepat
viru
mhv
bovin
coronaviru
bcv
nlink
infecti
bronchiti
viru
ibv
tgev
except
tgev
transloc
within
reticular
endoplasm
membran
occur
absenc
cleavabl
signal
sequenc
one
particular
coronavirus
virion
bud
occur
pregolgi
compart
tooz
et
al
consequ
addit
complex
type
chain
within
golgi
compart
may
take
place
either
free
virionassoci
glycoprotein
effect
glycosyl
inhibitor
virion
format
investig
earlier
studi
mhv
ibv
viral
particl
lack
protein
could
observ
thu
indic
glycosyl
protein
requir
protein
dispens
virion
format
rottier
et
al
holm
et
al
stern
sefton
niemann
et
al
main
object
present
studi
analys
contribut
glycosyl
antigen
makeup
two
protein
carbohydr
moieti
viral
nonvir
glycoprotein
gener
strong
influenc
antigen
reactiv
transport
function
activ
niman
elder
alexand
elder
skehel
et
al
macham
et
al
see
klenk
review
last
year
inform
monoclon
antibodi
bind
site
protein
coronavirus
tgev
mhv
ibv
obtain
led
local
epitop
group
epitop
call
site
primari
structur
tooz
stanley
cavanagh
et
al
lenstra
et
al
luytj
et
al
correa
et
al
posthumu
et
al
routledg
et
al
howev
contribut
carbohydr
express
epitop
yet
examin
report
carbohydr
composit
immunoreact
protein
differ
stage
matur
tgev
studi
result
demonstr
express
antigen
site
tgev
protein
strong
sitespecif
requir
respect
glycosyl
cotransl
addit
carbohydr
found
crucial
acquisit
mainten
antigen
site
tgev
glycoprotein
origin
high
passag
strain
tgev
pig
kidney
cell
line
use
propag
viru
describ
characterist
anti
antim
monoclon
antibodi
mab
use
studi
also
describ
see
tabl
ascit
fluid
felin
infecti
periton
viru
afip
employ
polyclon
reagent
tgev
polypeptid
procedur
metabol
label
viral
polypeptid
describ
elsewher
briefli
pd
cell
confluent
monolay
infect
multipl
pfu
per
cell
h
post
infect
pi
cell
label
cystein
pci
per
cell
ml
laud
et
al
delma
et
al
delma
laud
unpublish
result
methionin
cystinedeplet
eagl
mem
supplement
calf
serum
h
pi
monolay
rins
cell
extract
prepar
ml
ripa
lysi
buffer
triton
nacl
kcl
mm
mgci
kall
unitsml
aprotinin
result
cytosol
ultracentrifug
h
rpm
beckman
rotor
supernat
store
aliquot
c
immunoprecipit
assay
perform
previous
describ
procedur
purif
label
viru
describ
supernat
cell
cultur
label
collect
h
pi
centrifug
min
x
g
result
supernat
ultracentrifug
min
rpm
tla
rotor
beckman
pellet
resuspend
distil
water
store
c
tunicamycin
monensin
serva
ad
cell
medium
h
pi
h
addit
inhibitor
cultur
label
methionin
cystein
h
pi
ripa
cell
extract
prepar
describ
endo
vacetylglucosaminidas
h
endo
h
endo
nacetylglucosaminidas
f
endo
f
peptidenglycohydrolas
f
glyco
f
obtain
boehring
aliquot
label
virion
suspens
dilut
sd
triton
mercaptoethanol
mm
edta
mm
sodium
acet
ph
endo
h
digest
ph
endo
f
glyco
f
digest
sampl
treat
overnight
c
follow
enzym
concentr
endo
h
uml
endo
f
uml
glyco
f
uml
result
materi
precipit
volum
aceton
c
pellet
centrifug
x
g
min
pellet
wash
aceton
water
solubil
laemmli
buffer
endo
h
digest
cellular
extract
perform
follow
x
cell
solubil
ripa
buffer
dilut
tri
ph
sd
mm
pmsf
treat
mu
endo
h
overnight
c
tri
nacl
ad
protein
recov
immunoprecipit
infect
cell
treat
mocktreat
presenc
one
follow
drug
tunicamycin
antibiot
inhibit
transfer
en
bloc
asnlink
side
chain
monensin
ionophor
interfer
transport
protein
golgi
apparatu
thu
nonspecif
affect
addit
complex
type
sugar
side
chain
elbein
treatment
slight
effect
overal
cell
protein
synthesi
judg
level
incorpor
methionin
virusspecif
polypeptid
present
result
cell
extract
analyz
immunoprecipit
use
polyclon
reagent
sdspage
fig
pattern
control
sampl
similar
previous
describ
show
presenc
two
high
speci
repres
matur
protein
intracellular
precursor
respect
protein
band
major
speci
polypeptid
poorli
longer
detect
extract
cell
treat
tunicamycin
lgml
fig
la
instead
two
polypeptid
becam
appar
close
predict
apoprotein
respect
rasschaert
laud
remark
speci
poorli
immunoprecipit
compar
viral
polypeptid
present
tunicamycin
treat
cell
lack
cleav
addit
nondissoci
materi
indic
intrins
immunoreact
speci
markedli
decreas
treatment
pm
monensin
block
synthesi
matur
protein
yield
synthesi
speci
mobil
immunoreact
equival
speci
fig
lb
synthesi
minor
speci
presenc
monensin
markedli
affect
wherea
major
compon
polypeptid
composit
viru
particl
produc
presenc
one
two
drug
examin
virion
produc
tunicamycintr
cell
sediment
sucros
gradient
broader
band
compar
control
virion
fack
ail
form
speci
wherea
protein
present
form
virion
purifi
monensintr
cultur
exhibit
polypeptid
pattern
similar
control
virion
indic
inhibit
incomplet
howev
speci
appear
incorpor
extent
virion
data
shown
character
oligosaccharid
moieti
differ
form
protein
examin
suscept
differ
endoglycosidas
cleav
nlink
oligosaccharid
endo
h
cleav
predominantli
high
mannos
oligosaccharid
chain
glyco
f
cleav
high
mannos
complex
type
oligosaccharid
wherea
endo
f
cleav
high
mannos
hybrid
biantenna
complex
glycan
tarentino
et
al
fig
show
effect
enzym
purifi
virion
polypeptid
incub
endo
h
endo
f
caus
littl
shift
mobil
matur
protein
wherea
incub
glyco
f
gener
product
iv
thu
indic
notabl
proport
sugar
chain
remov
compon
found
sensit
three
nglycanas
lead
appear
speci
latter
assum
correspond
unglycosyl
polypeptid
sinc
comigr
backbon
product
synthes
presenc
tunicamycin
shown
speci
sensit
glyco
f
convert
speci
effect
endo
h
intracellular
virusspecif
polypeptid
also
examin
fig
speci
found
markedli
sensit
endo
h
digest
convert
product
respect
wherea
speci
essenti
resist
virionassoci
homolog
experi
reveal
reactiv
protein
produc
tunicamycintr
cell
toward
polyclon
antibodi
markedli
alter
investig
detail
influenc
glycosyl
antigen
protein
analyz
immunoreact
speci
produc
tunicamycintr
cell
toward
panel
mab
among
mab
direct
speci
defin
one
major
antigen
site
b
c
locat
aminohalf
polypeptid
chain
defin
topolog
unrel
epitop
six
mab
recogn
epitop
specif
precursor
speci
tabl
found
mab
exhibit
low
low
residu
reactiv
toward
speci
produc
presenc
tunicamycin
notabl
except
site
cspecif
mab
show
substanti
glycosyl
independ
partial
data
obtain
mab
repres
major
site
present
fig
order
preserv
possibl
fragil
antigenantibodi
complex
carrier
bead
wash
two
time
experi
explain
presenc
nonspecif
band
site
cspecif
mab
effici
immunoprecipit
speci
effect
endo
h
treatment
immunoreact
intracellular
speci
toward
antiss
mab
also
examin
fig
alreadi
shown
two
speci
latter
suscept
endo
h
deglycosyl
speci
react
site
c
mab
effici
polyclon
reagent
wherea
littl
reactiv
toward
site
b
mab
could
evidenc
contrast
apoprotein
apoprotein
react
effici
polyclon
antibodi
nevertheless
glycosyl
state
appear
influenc
express
certain
epitop
shown
dramat
alter
reactiv
mab
test
toward
speci
produc
tunicamycintr
cell
fig
mab
defin
epitop
spatial
unrel
other
see
tabl
l
show
reactiv
equival
glycosyl
form
protein
shown
number
virus
carbohydr
moieti
viral
glycoprotein
may
strong
influenc
antigen
well
function
activ
present
studi
address
natur
carbohydr
side
chain
contribut
antigen
makeup
two
major
envelop
glycoprotein
spike
protein
membran
protein
enteropathogen
porcin
coronaviru
tgev
tgev
shown
contain
asnnlink
sugar
garw
et
al
jacob
et
al
protein
found
appear
infect
cell
speci
design
remain
present
substanti
amount
throughout
viral
cycl
studi
speci
shown
convert
endo
h
speci
fig
consist
unglycosyl
speci
produc
tunicamycintr
cell
fig
la
predict
polypeptid
backbon
result
led
us
conclud
repres
glycopolypeptid
bear
rich
mannos
side
chain
contrast
speci
shown
essenti
resist
endo
h
digest
thu
establish
bear
predominantli
complex
type
side
chain
moreov
speci
longer
detect
presenc
monensin
fig
lb
indic
transit
result
golgi
specif
modif
oligosaccharid
present
speci
like
repres
triand
tetraantennari
complex
type
carbohydr
sinc
sensit
glyco
f
treatment
fig
protein
detect
tunicamycintr
cell
uniqu
speci
equival
predict
apoprotein
result
confirm
protein
nglycosyl
establish
observ
heterogen
intracellular
virionassoci
protein
essenti
repres
differ
state
glycosyl
major
speci
would
therefor
high
mannos
form
sensit
treatment
endo
h
wherea
speci
would
bear
complex
type
carbohydr
sinc
shown
sensit
glyco
f
fig
process
glycosyl
tgev
ibv
protein
thu
appear
similar
endo
h
sensit
endo
h
resist
speci
found
ibv
virion
stern
sefton
final
worth
mention
protein
found
tgev
virion
predominantli
high
mannos
type
wherea
speci
bear
essenti
complex
type
carbohydr
found
tgev
virion
find
impli
golgispecif
modif
poorli
effici
case
protein
major
object
studi
investig
contribut
carbohydr
express
differ
epitop
identifi
protein
inform
obtain
acquisit
immunoreact
protein
relat
carbohydr
process
summar
fig
express
epitop
defin
protein
greatli
alter
addit
c
rbohydr
block
tunicamycin
fig
strongli
suggest
epitop
locat
vicin
uniqu
glycosyl
site
predict
hydrophil
nterminu
assum
expos
extern
side
membran
epitop
defin
mab
shown
glycosyl
independ
would
consist
locat
intracytoplasm
domain
polypeptid
chain
nonreactivi
mab
membran
immunouoresc
experi
delma
laud
unpublish
data
support
view
find
unglycosyl
fig
la
deglycosyl
protein
fig
retain
strong
reactiv
sera
impli
least
one
giycosyl
independ
epitop
put
locat
endodomain
protein
potent
b
cell
induc
carbohydr
requir
express
individu
epitop
investig
use
panel
neutral
nonneutr
mab
shown
delin
four
major
antigen
site
b
c
locat
n
termin
half
molecul
unrel
epitop
delma
et
al
see
tabl
follow
result
led
us
conclud
antigen
site
highli
depend
upon
glycosyl
express
mainten
first
unglycosyl
intracellular
speci
produc
presenc
tunicamycin
exhibit
littl
reactiv
toward
mab
defin
site
b
fig
second
mab
recogn
poorli
deglycosyl
form
obtain
endo
h
treatment
infect
cell
extract
fig
definit
conclus
present
drawn
way
carbohydr
side
chain
modul
antigen
howev
observ
residu
reactiv
nonglycosyl
chain
indic
carbohydr
moieti
directli
involv
recognit
structur
epitop
rather
requir
proper
fold
nascent
glycopeptid
chain
third
contrast
site
site
c
reveal
larg
independ
core
glycosyl
express
fig
find
agre
earlier
observ
site
c
epitop
could
map
express
larg
fragment
gene
bacteri
express
system
bacteri
express
epitop
character
far
sl
subunit
mhv
subunit
ibv
lenstra
et
al
luytj
et
al
routledg
et
al
may
suggest
least
part
major
antigen
site
assum
locat
globular
part
sl
protein
see
laud
carbohydratedepend
found
protein
tgev
present
state
knowledg
concern
relationship
express
protein
epitop
coposttransl
process
summar
fig
combin
present
data
report
separ
studi
deal
oligomer
process
protein
tgev
accord
propos
model
biosynthesi
matur
protein
compris
three
main
event
first
speci
bear
high
mannos
side
chain
synthes
endoplasm
reticulum
er
monom
express
major
antigen
site
b
c
local
globular
part
molecul
among
site
c
larg
independ
coreglycosyl
express
next
step
shown
ratelimit
occur
er
consist
assembl
speci
x
oligom
structur
express
new
epitop
particular
specif
epitop
final
newli
assembl
trimer
transport
golgi
compart
terminalglycosyl
occur
specif
epitop
lost
consequ
golgimodif
conclus
cotransl
addit
sugar
nascent
polypeptid
chain
appear
play
key
role
antigen
make
glycoprotein
tgev
howev
express
particular
epitop
protein
shown
modul
oligomeris
termin
glycosyl
find
suggest
carbohydr
may
also
modul
immunogen
protein
